Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease
Clinical trial NCT02177786 · COMPLETED
Trial details
- NCT number
- NCT02177786
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-07-01
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.